1.
Atrial fibrillation: management: Guidance and guidelines, https://www.nice.org.uk/guidance/cg180, (2014).
2.
Keeling, D., Baglin, T., Tait, C., Watson, H., Perry, D., Baglin, C., Kitchen, S., Makris, M.: Guidelines on oral anticoagulation with warfarin - fourth edition. British Journal of Haematology. 154, 311–324 (2011). https://doi.org/10.1111/j.1365-2141.2011.08753.x.
3.
England, J.M., Hyde, K., Lewis, S.M., Mackie, I.J., Rowan, R.M., Bain, B.J., Matutes, E.M., Murphy, M.F., Reilly, J.T., Shinton, K., Stephens, A., Wood, J.K., Colvin, B.T., Machin, S.J., Baglin, T., Barrowcliffe, T.W., Greaves, M., Ludlam, C.A., Preston, F.E., Rose, P.E., Walker, I.D.: Guidelines for near patient testing: haematology. International Journal of Laboratory Hematology. 17, 301–310 (2013). https://doi.org/10.1111/j.1365-2257.1995.tb01269.x.
4.
Jennings, I., Kitchen, D., Keeling, D., Fitzmaurice, D., Heneghan, C.: Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists: guidance from the British Committee for Standards in Haematology. British Journal of Haematology. 167, 600–607 (2014). https://doi.org/10.1111/bjh.13070.
5.
Heneghan, C., Ward, A., Perera, R., Bankhead, C., Fuller, A., Stevens, R., Bradford, K., Tyndel, S., Alonso-Coello, P., Ansell, J., Beyth, R., Bernardo, A., Christensen, T.D., Cromheecke, M., Edson, R.G., Fitzmaurice, D., Gadisseur, A.P., Garcia-Alamino, J.M., Gardiner, C., Hasenkam, M., Jacobson, A., Kaatz, S., Kamali, F., Khan, T.I., Knight, E., Körtke, H., Levi, M., Matchar, D.B., Menéndez-Jándula, B., Rakovac, I., Schaefer, C., Siebenhofer, A., Souto, J.C., Sunderji, R., Gin, K., Shalansky, K., Völler, H., Wagner, O., Zittermann, A.: Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. The Lancet. 379, 322–334 (2012). https://doi.org/10.1016/S0140-6736(11)61294-4.
6.
Mant, J., Hobbs, F.D.R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G.Y.H., Murray, E.: Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. The Lancet. 370, 493–503 (2007). https://doi.org/10.1016/S0140-6736(07)61233-1.
7.
Fitzmaurice, D.A., Hobbs, F.D.R., Jowett, S., Mant, J., Murray, E.T., Holder, R., Raftery, J.P., Bryan, S., Davies, M., Lip, G.Y.H., Allan, T.F.: Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ. 335, 383–383 (2007). https://doi.org/10.1136/bmj.39280.660567.55.
8.
Fitzmaurice, D.A., Machin, S.J.: Recommendations for patients undertaking self management of oral anticoagulation. BMJ. 323, 985–989 (2001). https://doi.org/10.1136/bmj.323.7319.985.
9.
NHS Purchasing and Supply Agency: Buyers guide: point of care coagulometers for monitoring oral anticoagulation., http://nhscep.useconnect.co.uk/ShowDocument.ashx?id=58&i=true.
10.
Fitzmaurice, D.A., Murray, E.T. eds: Oral anticoagulation management and stroke prevention. Hayward Medical Communications, Newmarket (2013).
11.
NICE | The National Institute for Health and Care Excellence, https://www.nice.org.uk/.
12.
National Patient Safety Agency, http://www.npsa.nhs.uk/.
13.
Anticoagulation Europe, http://www.anticoagulationeurope.org/.
14.
British Society for Haematology, http://www.b-s-h.org.uk/.
15.
CLOT UK, http://www.clotuk.com/.